kff employer health benefits survey 2025 glp-1 coverage Benefit Summary of the KFF 2025

For people with obesity who struggle to feel full, GLP-1 agonists can help in restoring better control over appetite

In controlled studies on aged skin, GHK-Cu tightened skin, improved elasticity and firmness, and reduced fine lines, wrinkles and photodamage

The challenge is that these anti-aging claims remain far ahead of the available evidence

To understand the long-term safety and chronic effectiveness of these treatments, these studies will be essential

AOD-9604 vs GLP-1 Agonists (Semaglutide, Tirzepatide) GLP-1 receptor agonists like Semaglutide and Tirzepatide represent the current standard for medication-assisted weight loss, producing dramatic results averaging 15-20% total body weight reduction

10.1111/dom.14233